Applicant, as named in the Orange Book
Fonseca Biosciences
Next listed expiry: Xtoro on 21 Nov 2033. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Xtoro NDA 206307 finafloxacin | 21 Nov 2033 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.